Invention Grant
- Patent Title: MRI contrasting agent for contrasting cancer cell
-
Application No.: US14670805Application Date: 2015-03-27
-
Publication No.: US09765187B2Publication Date: 2017-09-19
- Inventor: Taeghwan Hyeon , Kun Na , Daishun Ling , Wooram Park , Byung Hyo Kim , Hyeona Yim , Kyoung Sub Kim , Michael J. Hackett , Sin-jung Park , Yang Lu , Yong Sun Jeon
- Applicant: SNU R&DB FOUNDATION , Institute for Basic Science , The Catholic University of Korea Industry-Academic Cooperation Foundation
- Applicant Address: KR KR KR
- Assignee: SNR R&DB FOUNDATION,INSTITUTE FOR BASIC SCIENCE,THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC
- Current Assignee: SNR R&DB FOUNDATION,INSTITUTE FOR BASIC SCIENCE,THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC
- Current Assignee Address: KR KR KR
- Agency: Dergosits & Noah LLP
- Agent Todd A. Noah
- Priority: KR10-2014-0129020 20140926
- Main IPC: A61K49/06
- IPC: A61K49/06 ; C08G69/08 ; C08G69/40 ; C08G81/00 ; A61K49/18

Abstract:
The present invention relates to MRI contrasting agent for contrasting cancer cell which contains ultrafine nanoparticles. More particularly, the present invention is directed to a self-assembled ligand composition comprising a ligand A, which is separated at a specific pH range, and a ligand B of which surface charge changes at a specific pH range, MRI contrast agent for contrasting cancer cell comprising said ligand composition and MRI contrasting nanoparticles, and the methods for preparing them.
Public/Granted literature
- US20160089455A1 MRI CONTRASTING AGENT FOR CONTRASTING CANCER CELL Public/Granted day:2016-03-31
Information query